The p.Ser107Leu in BICD2 is a mutation 'hot spot' causing distal spinal muscular atrophy. by Bansagi, Boglarka et al.
LETTER TOTHE EDITOR
The p.Ser107Leu in BICD2 is a mutation ‘hot spot’ causing distal spinal muscular
atrophy
Boglarka Bansagi,1,2,* Helen Griffin,1,2,* Venkateswaran Ramesh,3,* Jennifer Duff,2
Angela Pyle,2 Patrick F. Chinnery2 and Rita Horvath1,2
*These authors contributed equally to this work.
1 The John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine,
Newcastle University, Newcastle upon Tyne, UK
2 Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
3 Department of Paediatric Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospitals NHS Trust,
Newcastle upon Tyne, UK
Correspondence to: Dr Rita Horvath,
Institute of Genetic Medicine,
Newcastle University,
Newcastle upon Tyne,
NE1 3BZ,
UK
E-mail: Rita.Horvath@ncl.ac.uk
Sir,
We read with great interest the recent paper by Rossor et al.
(2015), reporting two new patients and summarizing obser-
vations on 30 previously published patients worldwide with
BICD2-related spinal muscular atrophy. The work provides
a timely overview of the main clinical characteristics
observed in patients carrying the six currently known dom-
inant BICD2 mutations. The paper also highlights the cur-
rent knowledge of the structural and interaction specificities
of BICD2 protein affected by the described missense muta-
tions and supports dynein-dynactin trafficking impairment as
a common pathomechanism (Oates et al., 2013).
The most common BICD2 mutation reported in four of
the nine families was c.320C4T, p.Ser107Leu. The muta-
tion in two large pedigrees originating from Australia and
Austria fell on a shared eight single nucleotide polymorph-
ism (SNP) haplotype, spanning a 0.1Mb region and with a
background frequency of 2% in the European population,
suggesting a recent founder mutation between the two
families. The same haplotype background was predicted
in another affected family from the USA with European
ancestors. A four-generation Bulgarian family with
Turkish ethnic origin, originally reported by Peeters et al.
(2013), was the fourth family carrying the same mutation
within a 12.7Mb region of linkage. In this family the dis-
ease arose as a consequence of a de novo mutation in the
proband. In addition a three-generation Dutch family pub-
lished by Neveling et al. (2013), had a similar phenotype
and carried the same c.320C4T, p.Ser107Leu missense
mutation within a 10Mb region of linkage.
Here, we would like to expand the clinical presentation
and haplotype background of the p.Ser107Leu BICD2 mu-
tation with five additional patients from two North UK
families (Fig. 1). A 41-year-old mother presented with her
three children affected by the same disorder (Family 1). She
had a longstanding history of muscle weakness that has
remained stable throughout her life. She was born with
toe deformities and had mildly delayed motor development.
She always had difficulties rising from the floor and with
physical exercise. She developed a locked jaw in her uni-
versity years and she was provided with a night splint to
prevent its recurrence. On neurology examination she had
mild weakness both proximally and distally in her lower
limbs. She had a positive Gower’s manoeuvre and she
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could not perform heel walking. Muscle strength in her
upper limbs was entirely preserved but there was a mild
scapular winging on the left side. Her deep tendon reflexes
were brisk and asymmetric in her upper limbs. No cranial
nerve involvement and sensory impairment were found.
Except for a mildly elevated creatine kinase (292U/l,
normal 5200), all other laboratory parameters were
normal. Sensorimotor nerve conduction velocities and
action potentials were within the normal ranges. On elec-
tromyography she had evidence of severe chronic neuro-
genic changes in both her upper and lower limbs. The
findings were compatible with segmental motor neurono-
pathy. Her muscle MRI showed symmetrical prominent
fatty replacement of gluteus medius, vastus lateralis,
rectus femoris, semi-membranosus, lateral and medial
gastrocnemius.
Her pregnancies and deliveries were uncomplicated. Her
first born, currently 6-year-old daughter was noted to have
a minor foot abnormality at birth. She did not walk until
20 months of age, and started walking on the medial aspect
of her feet. The 5-year-old twin brothers had a very similar
clinical course. Both had mild motor delay, and currently
have mild weakness in both proximal and distal muscles of
their lower limbs associated with disproportionate atrophy
of the distal muscles (Fig. 1). Their upper body and arms
are particularly strong with good manual dexterity but they
show mild scapular winging. All three children have diffi-
culties with rising from the floor, climbing stairs, running
and they cannot perform heel walking. All receive physio-
therapy and orthotic support. All four family members
have normal cognition.
Another North British individual patient had no family
history of neuromuscular disease (Family 2). His parents
were non-consanguineous and healthy, and his older
brother is asymptomatic. The proband was born from an
unremarkable pregnancy and delivery, but at birth he was
noted with congenital bilateral talipes. After trials of
physiotherapy and serial castings of his foot, the deformity
was surgically corrected at age 1 year. His motor develop-
ment was subsequently delayed, and he started walking
only around the age of 3 years. He remained ambulant
with a waddling gait, but he requires wheelchair support
for longer distances. His cognition is normal.
On examination he had mild weakness, predominantly in
the proximal muscles of his lower limbs accompanied by
marked atrophy in the hip muscles. There was prominent
muscle amyotrophy of both anterior and posterior com-
partments below the knee. He had full muscle power in
Figure 1 Pedigrees and clinical presentations of 2 new families carrying the p.Ser107Leu mutation in BICD2. (A) Pedigrees of the North
UK families. Probands of each family are indicated by an arrow. (B) Image of the proband and her three affected children from Family 1 presenting with
lower limb wasting and feet deformities. (C) Images of proband from Family 2 demonstrating wasting of lower extremities and his postsurgical feet position.
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the shoulders and upper limbs but he showed scapular
winging bilaterally. Upper limb reflexes were easy to elicit
while lower limb reflexes were reduced. He walked with a
high-steppage gait and he could not achieve heel strike.
Sensation was preserved. Nerve conduction studies were
normal. Electromyography revealed fibrillation potentials
and positive sharp waves and motor units were of mark-
edly increased amplitude, polyphasic and unstable, suggest-
ing chronic neurogenic process with spinal motor neuron
involvement. Muscle biopsy showed neurogenic fibre atro-
phy but no other specific changes.
The clinical presentation of these five new patients is simi-
lar to the patients reported by Rossor et al. (2015); however,
we would emphasize that all our patients showed scapular
winging, which we believe is a common feature of BICD2
deficiency. The heterozygous c.320C4T, p.Ser107Leu muta-
tion is the cause of the disease in both families. It followed
an autosomal dominant inheritance pattern in Family 1,
however it is de novo in Family 2, as both parents were
tested negative. It is indicating that the c.320C4T,
p.Ser107Leu mutation arose independently in these two
families. This mutation is located in a methylated CpG di-
nucleotide suggesting that recurrent mutations may occur at
this position due to methylation-mediated deamination.
To determine whether the c.320C4T, p.Ser107Leu muta-
tion in Family 1 is present on the same haplotype background
as three of the families reported by Rossor et al. (2015) or
rather is a mutational hot spot, we performed haplotype ana-
lysis. HapMap (data release 28) SNP genotype data from the
CEU population, in a region surrounding BICD2 were used
to generate Haplotypes in Haploview (www.broadinstitute.
org). There were 10 different haplotypes present in the CEU
European population in a single 0.1Mb block (Fig. 2).
Genotypes from whole exome sequence data were present
for the first five SNPs of the haplotypes and genotyping of
a further seven haplotype tagging SNPs allowed us to show
that the mutation was carried on a different haplotype back-
ground each of our two families. Additionally, the mutation-
carrying haplotype in Family 1 was present in 9.8% of the
HapMap European population, which is presumably different
from the haplotype reported by Rossor et al. (2015), which
was present in only 2% of Europeans. Our haplotype analysis
excludes the presence of a common founder mutation and
further supports the theory that the c.320C4T position is
as a mutational hot spot.
The detection of more de novo cases suggests that the
diagnosis of BICD2 mutations should be considered even
with no positive family history, and particularly when there
is scapular winging associated with early onset distal lower
limb motor neuropathy.
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Figure 2 Ten European haplotype blocks in a 0.1Mb region surrounding BICD2 from Haplotype SNP IDs 01 (rs556) to 89
(rs10117449). The BICD2 c.320C4T mutation is located between SNPs 19 and 20. Haplotype SNPs 01, 04, 05, 07 and 08 were genotyped from
whole exome sequence; SNPs 15, 19, 52, 63, 73, 88 and 89 were genotyped from Sanger sequence (blue arrows). Affected members of Family 1
shared haplotype block 3 (yellow box), present in the HapMap CEU population at a frequency of 0.098. The affected proband in Family 2 had
haplotype blocks 2 and 4 (red and blue boxes) in the region surrounding the mutation; recombination not observed in the CEU population
occurred between SNPs 63 and 73, so that this proband also had part of either blocks 7, 8 or 10.
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